Pulmatrix, Inc. (PULM) Social Stream



Pulmatrix, Inc. (PULM): $6.03

0.41 (+7.30%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

Add PULM to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#104 of 386

in industry

Featured Post From StockTwits About PULM

$PULM
Just reread latest 10Q with a fine-toothed comb. I also compared it to previous 10Q in May. In most recent 10Q, MGT does not mention one time, the possibility of reacquiring Pulmazole for 25% of its Fair Market Value, while in previous 10Q, it states that phrase 5 times. Also, noticed them mentioning how arbitration would be very costly and risky, as their could be counterclaims by Cipla and this could go on forever and prevailing party would have to pay other party's legal fees. Most logical conclusion here is a negotiated settlement. Most likely, Pulm will have to cave in some and amend the agreement. This will be the cheapest and quickest way to get back on track.
HFHInc, published August 14, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!